French research infrastructures to develop and validate glioma biomarkers

Neurosurgery

Volumn 75, Issue 2, 2014, Pages

  Menei, Philippe ^a   Figarella Branger, Dominique ^a   Bauchet, Luc ^a   Loiseau, Hugues ^a   Denyset, Marina ^a   Roman, Tanguy ^a   Dehais, Caroline ^a   Delattre, Jean Yves ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CANCER GRADING; CORRELATIONAL STUDY; FOLLOW UP; GLIOBLASTOMA; GLIOMA; HUMAN; LETTER; MEDULLOBLASTOMA; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PRIORITY JOURNAL; BRAIN TUMOR; INFORMATION SCIENCE; NEUROIMAGING; PATHOLOGY; PROCEDURES; REGISTER;

BRAIN NEOPLASMS; HUMANS; INFORMATICS; NEUROIMAGING; REGISTRIES;

EID: 84904982073     PISSN: 0148396X     EISSN: 15244040     Source Type: Journal    
DOI: 10.1227/NEU.0000000000000364     Document Type: Letter

References (4)

1. Fouke SJ, Benzinger TL, Milchenko M, et al. The Comprehensive Neuro- Oncology Data Repository (CONDR): a research infrastructure to develop and validate imaging biomarkers. Neurosurgery. 2014;74(1):88-98.
2. Reyes-Botero G, Dehais C, Idbaih A, et al. Contrast enhancement in 1p19q codeleted anaplastic oligodendrogliomas is associated with 9p loss genomic instability and angiogenic gene expression. Neurooncology. 2014;16(5):662-670.
3. Idbaih A, Ducray F, Dehais C, et al. SNP array analysis reveals novel genomic abnormalities including copy neutral loss of heterozygosity in anaplastic oligodendrogliomas. PLoS One. 2012;7(10):e45950.
4. Rigau V, Zouaoui S, Mathieu-Daudé H, et al. French brain tumor database: 5-year histological results on 25 756 cases. Brain Pathol. 2011;21(6):633-644.